Dec 5 (Reuters) - Medical device maker Insulet (PODD.O) convinced a jury that Korean rival EOFlow (294090.KQ) owes it $452 million in damages for stealing trade secrets related to insulin pumps
The UPC Court of Appeal has overturned the first-instance decision in Insulet vs Eoflow, taking a fundamentally different view on the role of expert opinions in PI proceedings. It is currently
total 1 pages, 2 items